Systematic review of microsatellite instability and colorectal cancer prognosis

S Popat, R Hubner, RS Houlston - Journal of clinical oncology, 2005 - ascopubs.org
Purpose A number of studies have investigated the relationship between microsatellite
instability (MSI) and colorectal cancer (CRC) prognosis. Although many have reported a …

A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease …

T Kimura, K Kozuma, K Tanabe… - European heart …, 2015 - academic.oup.com
Aims Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term
results compared with permanent metallic drug-eluting stents (DESs). However, whether …

REGEN-COV antibody combination and outcomes in outpatients with Covid-19

DM Weinreich, S Sivapalasingam… - … England Journal of …, 2021 - Mass Medical Soc
Background In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the
monoclonal antibodies casirivimab and imdevimab, reduced the viral load and number of …

[HTML][HTML] Ketamine versus ECT for nonpsychotic treatment-resistant major depression

A Anand, SJ Mathew, G Sanacora… - … England Journal of …, 2023 - Mass Medical Soc
Background Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are
both currently used for treatment-resistant major depression, but the comparative …

Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial

SD Pokorney, GM Chertow, HR Al-Khalidi, D Gallup… - Circulation, 2022 - Am Heart Assoc
Background: There are no randomized data evaluating the safety or efficacy of apixaban for
stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial …

[HTML][HTML] Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial

WD Chey, F Mégraud, L Laine, LJ López, BJ Hunt… - Gastroenterology, 2022 - Elsevier
Background & aims Novel, effective treatments for Helicobacter pylori infection are needed.
This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, vs …

[HTML][HTML] AR101 oral immunotherapy for peanut allergy

PALISADE Group of Clinical … - New England Journal of …, 2018 - Mass Medical Soc
Background Peanut allergy, for which there are no approved treatment options, affects
patients who are at risk for unpredictable and occasionally life-threatening allergic reactions …

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label …

CJ Langer, SM Gadgeel, H Borghaei… - The lancet …, 2016 - thelancet.com
Background Limited evidence exists to show that adding a third agent to platinum-doublet
chemotherapy improves efficacy in the first-line advanced non-small-cell lung cancer …

Transfusion of plasma, platelets, and red blood cells in a 1: 1: 1 vs a 1: 1: 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial

JB Holcomb, BC Tilley, S Baraniuk, EE Fox, CE Wade… - Jama, 2015 - jamanetwork.com
Importance Severely injured patients experiencing hemorrhagic shock often require massive
transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red …

[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …